{"id":"W2033997665","doi":"10.1007/s10637-011-9650-4","title":"A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium","year":2011,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; McGill University Health Centre; University of Alberta; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Cancer; Gastroenterology; Clinical endpoint; Adenocarcinoma; Oncology; Phases of clinical research; Chemotherapy; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003922274,0.0003330385,0.0006423654,0.0002749256,0.0001720741,0.0000116191,0.0003136339,0.00006786926,0.0002561592],"category_scores_gemma":[0.0009063657,0.0001783693,0.000213385,0.001314928,0.0004825486,0.0002457219,0.0001766285,0.0003052132,0.000002597167],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001556323,"about_ca_system_score_gemma":0.001875981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001892624,"about_ca_topic_score_gemma":0.00007314075,"domain_scores_codex":[0.9967324,0.0001966765,0.001149389,0.0004110902,0.001165819,0.0003445938],"domain_scores_gemma":[0.9978394,0.0001870415,0.0009596641,0.0005210151,0.0002749846,0.0002178897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9489641,0.0127134,0.01804489,0.0002275367,0.0003374415,0.00002638197,0.00284542,0.00007627487,0.0004065413,0.0004701645,0.004282854,0.01160504],"study_design_scores_gemma":[0.9144779,0.0331317,0.04712744,0.0004250826,0.0008449854,0.00001123596,0.0003431901,0.000176039,0.002524949,0.0003387239,0.0003709672,0.0002277919],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937251,0.00003939744,0.0001220438,0.0009113271,0.0007641737,0.004206497,0.00007113472,0.00002492924,0.0001353472],"genre_scores_gemma":[0.9941753,0.000003320651,0.00294829,0.0005281306,0.0002911736,0.0001634119,0.00007176193,0.00003246032,0.001786214],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03448616,"threshold_uncertainty_score":0.7273691,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03554854809381155,"score_gpt":0.2814283974656747,"score_spread":0.2458798493718632,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}